{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T09:03:32Z","timestamp":1774861412860,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ejso.2024.108545","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T02:17:48Z","timestamp":1720923468000},"page":"108545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trials of interventions for ovarian and testicular germ cell tumors registered in ClinicalTrials.gov: A cross-sectional study"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8467-6061","authenticated-orcid":false,"given":"Livia","family":"Puljak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9561-6550","authenticated-orcid":false,"given":"Ruzica","family":"Bojcic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5821-6785","authenticated-orcid":false,"given":"Monika","family":"Cikes Botic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8341-9760","authenticated-orcid":false,"given":"Zdravko","family":"Odak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8922-8823","authenticated-orcid":false,"given":"Nicoletta","family":"Riva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7536-7911","authenticated-orcid":false,"given":"Vienna R.","family":"Gold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8140-2107","authenticated-orcid":false,"given":"Ylenia","family":"Tabone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5705-2897","authenticated-orcid":false,"given":"Alessandro","family":"Squizzato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6369-0297","authenticated-orcid":false,"given":"Jean","family":"Calleja-Agius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ejso.2024.108545_bib1","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/s41568-019-0178-9","article-title":"Human germ cell tumours from a developmental perspective","volume":"19","author":"Oosterhuis","year":"2019","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"10.1016\/j.ejso.2024.108545_bib2","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.2214\/AJR.15.15199","article-title":"Ovarian cancer, the revised FIGO staging system, and the role of imaging","volume":"206","author":"Javadi","year":"2016","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"10.1016\/j.ejso.2024.108545_bib3","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/01.AOG.0000216004.22588.ce","article-title":"Incidence and survival rates for female malignant germ cell tumors","volume":"107","author":"Smith","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ejso.2024.108545_bib4","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ygyno.2005.02.007","article-title":"Ovarian cancer incidence in the United States, 1992-1999","volume":"97","author":"Quirk","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2024.108545_bib5","unstructured":"American Cancer Society. 5-year relative survival rates for ovarian (or fallopian tube) cancer. Available at: https:\/\/www.cancer.org\/cancer\/ovarian-cancer\/detection-diagnosis-staging\/survival-rates.html."},{"issue":"3","key":"10.1016\/j.ejso.2024.108545_bib6","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ygyno.2004.11.027","article-title":"Outcome and prognostic factors in ovarian germ cell malignancies","volume":"96","author":"Lai","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2024.108545_bib7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.mpdhp.2020.03.006","article-title":"Pathology of malignant ovarian germ cell tumours","volume":"26","author":"Kaur","year":"2020","journal-title":"Diagn Histopathol"},{"issue":"9","key":"10.1016\/j.ejso.2024.108545_bib8","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.2217\/fon.09.116","article-title":"Etiologic factors in testicular germ-cell tumors","volume":"5","author":"McGlynn","year":"2009","journal-title":"Future Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2024.108545_bib9","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.eururo.2013.11.004","article-title":"International variations and trends in testicular cancer incidence and mortality","volume":"65","author":"Znaor","year":"2014","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.ejso.2024.108545_bib10","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.eururo.2015.07.044","article-title":"Guidelines on testicular cancer: 2015 update","volume":"68","author":"Albers","year":"2015","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.ejso.2024.108545_bib11","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.ejso.2024.108545_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF01321540","article-title":"Years of potential life lost: evaluating premature cancer death in men","volume":"14","author":"Friman","year":"1989","journal-title":"J Community Health"},{"key":"10.1016\/j.ejso.2024.108545_bib13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.12703\/r\/10-67","article-title":"Recent advances in testicular germ cell tumours","volume":"10","author":"Mele","year":"2021","journal-title":"Fac Rev"},{"issue":"8","key":"10.1016\/j.ejso.2024.108545_bib14","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1200\/JOP.19.00190","article-title":"Germ cell tumors in adolescents and young adults","volume":"15","author":"Fonseca","year":"2019","journal-title":"J Oncol Pract"},{"issue":"11","key":"10.1016\/j.ejso.2024.108545_bib15","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1016\/j.celrep.2018.05.039","article-title":"Integrated molecular Characterization of testicular germ cell tumors","volume":"23","author":"Shen","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.ejso.2024.108545_bib16","doi-asserted-by":"crossref","DOI":"10.1097\/CCO.0000000000000933","article-title":"Challenges in the management of relapsed germ cell tumors","author":"Salous","year":"2023","journal-title":"Curr Opin Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2024.108545_bib17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/his.13102","article-title":"The world Health Organization 2016 classification of testicular germ cell tumours: a review and update from the International Society of Urological Pathology testis Consultation Panel","volume":"70","author":"Williamson","year":"2017","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.ejso.2024.108545_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13030493","article-title":"GYNOCARE update: Modern Strategies to improve diagnosis and treatment of rare gynecologic tumors-current Challenges and Future Directions","volume":"13","author":"Di Fiore","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ejso.2024.108545_bib19","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12874-022-01730-6","article-title":"Reporting of the safety from allergic rhinitis trials registered on ClinicalTrials.gov and in publications: an observational study","volume":"22","author":"Paladin","year":"2022","journal-title":"BMC Med Res Methodol"},{"issue":"11","key":"10.1016\/j.ejso.2024.108545_bib20","doi-asserted-by":"crossref","first-page":"909","DOI":"10.2217\/cer-2021-0012","article-title":"Outcome domains and measures for pain in psoriasis used in registered trials: analysis of studies on ClinicalTrials.gov","volume":"10","author":"Vucemilovic","year":"2021","journal-title":"J Comp Eff Res"},{"issue":"4","key":"10.1016\/j.ejso.2024.108545_bib21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.48286\/aro.2022.57","article-title":"Rapid systematic review of clinical trials on pharmacological therapies for rare gynecological cancers","volume":"2","author":"Harasani","year":"2022","journal-title":"Annals of Research in Oncology"},{"issue":"2","key":"10.1016\/j.ejso.2024.108545_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014701","article-title":"The quality of registration of clinical trials","volume":"6","author":"Viergever","year":"2011","journal-title":"PLoS One"},{"issue":"9438","key":"10.1016\/j.ejso.2024.108545_bib23","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0140-6736(04)17034-7","article-title":"Clinical trial registration: a statement from the International Committee of medical Journal Editors","volume":"364","author":"De Angelis","year":"2004","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ejso.2024.108545_bib24","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12916-018-1168-6","article-title":"Registration of published randomized trials: a systematic review and meta-analysis","volume":"16","author":"Trinquart","year":"2018","journal-title":"BMC Med"},{"issue":"5","key":"10.1016\/j.ejso.2024.108545_bib25","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/PPO.0b013e3181bdc2e0","article-title":"Overall survival: still the gold standard: why overall survival remains the definitive end point in cancer clinical trials","volume":"15","author":"Driscoll","year":"2009","journal-title":"Cancer J"},{"issue":"12","key":"10.1016\/j.ejso.2024.108545_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001566","article-title":"Timing and completeness of trial results posted at ClinicalTrials.gov and published in journals","volume":"10","author":"Riveros","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.ejso.2024.108545_bib27","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jpsychires.2023.04.004","article-title":"Depression trial results: a cross-sectional study of ClinicalTrials.gov","volume":"161","author":"Schmaling","year":"2023","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.ejso.2024.108545_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2022.106785","article-title":"Characteristics of clinical trials associated with early results reporting at ClinicalTrials.gov","volume":"117","author":"Bashir","year":"2022","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.ejso.2024.108545_bib29","doi-asserted-by":"crossref","first-page":"k1452","DOI":"10.1136\/bmj.k1452","article-title":"How to avoid common problems when using ClinicalTrials.gov in research: 10 issues to consider","volume":"361","author":"Tse","year":"2018","journal-title":"BMJ"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798324005973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798324005973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T08:14:54Z","timestamp":1774858494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798324005973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0748798324005973"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2024.108545","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trials of interventions for ovarian and testicular germ cell tumors registered in ClinicalTrials.gov: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2024.108545","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108545"}}